Skip to main content
Dhan
Search
Search
Loading...
Scanning the Markets...

Home

GSP Crop Science IPO Listing: Shares list at a premium of 4% on BSE and at 2.5% at NSE


GSP Crop Science IPO Listing: Shares list at a premium of 4% on BSE and at 2.5% at NSE

GSP Crop Science Limited, an Ahmedabad-based research-driven agrochemical manufacturer, today made its official entry to the Indian capital markets, offering Rs. 400 crore worth of shares to the general public.

Fact Checked
Team Dhan
Team Dhan
|Mar 24, 2026, 10:59 AM
TelegramXLinkedIn
Add as a preferred source on Google
GSP Crop Science IPO Listing: Shares list at a premium of 4% on BSE and at 2.5% at NSE


Listing its shares at both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE), the company has gained a milestone achievement in its four-decade-long journey of offering crop protection solutions to Indian and global farmers.

The initial public offering (IPO) worth Rs. 400 crore is strategically intended for reducing the company's borrowing load and for funding general corporate expansion. Despite the strong fundamentals and attractive valuation, the IPO today listed at a flat rate and opened at a marginal premium of 4% on BSE and 2.5% on NSE to its upper price band of Rs. 320. Here, we will explore the listing performance of GSP Crop Science Limited IPO in detail.

GSP Crop Science IPO Listing Performance 

On the morning of March 24, 2026, GSP Crop Science shares made a muted debut on Dalal Street, which reflected the cautious and flat market sentiment that had been witnessed in its prelisting grey market (GMP) of Rs. 2 during the past week. The stock opened at Rs. 332.30 on BSE, which was at a premium of 4% over its issue price of Rs. 320. On the NSE, it was listed at Rs. 328 at a premium of 2.50%. Following the listing, the stock was trading in the range of its issue price in the early trading hours.

According to market analysts, the flat listing was largely expected due to the subdued retail participation and broader market caution within the agriculture sector, which is currently dealing with erratic weather patterns and price volatility of raw materials. However, unlike some recent overvalued tech IPOs, the GSP Crop Science IPO did not list at a discount. Analysts attribute this stability to its highly reasonable valuation, priced at a Price-to-Earnings (P/E) multiple of about 9.6x based on the FY25 earnings, which had a slight margin of safety for investors.

Despite the tepid opening, long-term institutional interest is steady, with investors drawn to the company's robust R&D pipeline and integrated manufacturing model.

GSP Crop Science IPO Journey 

The public issue for GSP Crop Science started with the subscription window from March 16 to March 18, 2026. The company offered shares within the price band of Rs. 304 to Rs. 320. The issue size of ₹400 crore was a mix of a fresh issue of ₹240 crore (majorly to be used for repayment of outstanding debt of ₹170 crore) and an offer for sale (OFS) of ₹160 crore by the existing promoter shareholders.

The IPO witnessed an overall subscription of 1.64 times. The demand was primarily driven by Non-Institutional Investors (NIIs), who subscribed 3.14 times their allotted quota, and then Qualified Institutional Buyers (QIBs), with a bid of 2.66 times. Retail investors, on the other hand, remained highly restrained, with subscriptions of only 0.42 times. 

Ahead of the public bidding, the company successfully raised Rs. 120 crores from anchor investors, signalling a strong institutional trust. GSP Crop Science entered the IPO market with strong financial health. The company has a total income of Rs 1,301.06 crore in FY25 with a robust Profit After Tax (PAT) of Rs 81.42 crore.

Wrap up 

The listing of GSP Crop Science is symbolic of continued Indian economic dependence on agriculture and chemical manufacturing sectors. While the flat listing might disappoint short-term traders looking for immediate listing gains, the long-term play for GSP Crop Science is attractive due to its strong fundamentals.

As the company starts its journey as a listed company, its aggressive approach towards debt reduction by using IPO proceeds of Rs. 170 crore for prepaying borrowings will lead to immediate improvement in its interest coverage ratio, along with massive cash flows. Moving forward, the company's ability to capitalise on its intellectual property portfolio, which contains 524 product registrations and more than 100 granted patents, will be key.


fuzz
ipo banner

Read More on Ipo

Pre-apply for Upcoming IPOs